The Great Hold-Up: European Markets Tiptoe Ahead of Fed's Big Call Midday Market Mayhem: Unpacking the Wild Swings of Qualcomm, Organon, and a Rising Star The Biotech Gambit: Novartis Reportedly Eyes Avidity in a High-Stakes Acquisition The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic